Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
55 /100
HIGH RISK
Score updated Sep 12, 2026

ADVB — Advanced Biomed Inc. Dilution Risk Tracker

Track ADVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ADVB — Get alerts when the score changes →

As of September 12, 2026, Advanced Biomed Inc. (ADVB) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Advanced Biomed Inc. has a market capitalization of $8.19M, 1.38M shares outstanding, 3 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔔 Track ADVB — Get forecast alerts →

Market Data

Market Cap$8.19M
Shares Outstanding1.38M
Float629.7K
Cash$2.60M
Debt$712.5K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore55/100DilutionWatch score record
Shares Outstanding1.38MVerified float table or market cache
Public Float629.7KVerified float table or market cache
Market Cap$8.19MMarket data cache
Cash Runway5.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 8-K 3, 8-K/A 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 83.2% shares (2025Q4 vs prior)
3 institutional holders · 44.1K shares
#1 XTX Topco Ltd 27.3K shares
#2 Virtu Financial LLC 12.6K shares
#3 UBS Group AG 4.3K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest16.4K
Days to Cover1.0
% of Float2.6%
FINRA data as of Aug 31, 2026

Recent SEC Activity

8-K 8K EVENT 2026-05-01
8-K 8K EVENT 2026-04-03
8-K/A 8K EVENT 2026-02-10
8-K 8K EVENT 2026-02-02
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ADVB Dilution Snapshot

Advanced Biomed Inc. (ADVB) has a DilutionScore of 55/100, rated High dilution risk. Score date: September 12, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ADVB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ADVB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ADVB
ADVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.